Mineralocorticoid receptor haplotypes sex-dependently moderate depression susceptibility following childhood maltreatment

Psychoneuroendocrinology

Volumn 54, Issue , 2015, Pages 90-102

  Vinkers, Christiaan H ^a   Joëls, Marian ^a   Milaneschi, Yuri ^b   Gerritsen, Lotte ^b   Kahn, René S ^a   Penninx, Brenda W J H ^b   Boks, Marco P M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Early life adversity; Early life stress; Gender dependent; Major depressive disorder; Mineralocorticoid receptor; NR3C2; Sex dependent

Indexed keywords

MINERALOCORTICOID RECEPTOR;

ADULT; AGED; ARTICLE; CHILD ABUSE; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DISEASE PREDISPOSITION; EARLY LIFE STRESS; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINERALOCORTICOID RECEPTOR GENE; NETHERLANDS; PRIORITY JOURNAL; SEX DIFFERENCE; SEX ROLE; ADOLESCENT; GENETIC PREDISPOSITION; GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD ABUSE; DEPRESSION; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, MINERALOCORTICOID; SEX FACTORS; YOUNG ADULT;

EID: 84924452936     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2015.01.018     Document Type: Article

References (57)

1. Barrett Mueller K., Lu Q., Mohammed N., Luu V., McCurely A., Williams G., Adler G., Karas R.I.Z.J. Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function. Endocrinology 2014, 155(11):4461-4472. 10.1210/en.2014-1270.
2. Berardelli R., Karamouzis I., D'Angelo V., Zichi C., Fussotto B., Giordano R., Ghigo E., Arvat E. Role of mineralocorticoid receptors on the hypothalamus-pituitary-adrenal axis in humans. Endocrine 2013, 43:51-58. 10.1007/s12020-012-9750-8.
3. Bernstein D.P., Fink L. Childhood Trauma Questionnaire: A Retrospective Self-report 1998, Manual Psychol. Corp., San Antonio, TX.
4. Bernstein D.P., Fink L., Handelsman L., Foote J., Lovejoy M., Wenzel K., Sapareto E., Ruggiero J. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am. J. Psychiatry 1994, 151:1132-1136.
5. Bjartmar L., Johansson I.M., Marcusson J., Ross S.B., Seckl J.R., Olsson T. Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat. Psychopharmacology (Berl.) 2000, 151:7-12. 10.1007/s002130000468.
6. Burgess L.H., Handa R.J. Estrogen-induced alterations in the regulation of mineralocorticoid and glucocorticoid receptor messenger RNA expression in the female rat anterior pituitary gland and brain. Mol. Cell Neurosci. 1993, 4(2):191-198. 10.1006/mcne.1993.1023.
7. Carey M.P., Deterd C.H., de Koning J., Helmerhorst F., de Kloet E.R. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J. Endocrinol. 1995, 144:311-321. 10.1677/joe.0.1440311.
8. Castrén M., Patchev V.K., Almeida O.F., Holsboer F., Trapp T., Castrén E. Regulation of rat mineralocorticoid receptor expression in neurons by progesterone. Endocrinology 1995, 136:3800-3806.
9. Cyranowski J.M., Frank E., Young E., Shear M.K. Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model. Arch. Gen. Psychiatry 2000, 57:21-27. 10.1001/archpsyc.57.1.21.
10. De Graaf R., Bijl R.V., Smit F., Vollebergh W.A., Spijker J. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am. J. Psychiatry 2002, 159:620-629.
11. DeRijk R.H., van Leeuwen N., Klok M.D., Zitman F.G. Corticosteroid receptor-gene variants: modulators of the stress-response and implications for mental health. Eur. J. Pharmacol. 2008, 585:492-501. 10.1016/j.ejphar.2008.03.012.
12. DeRijk R.H., Wüst S., Meijer O.C., Zennaro M.-C., Federenko I.S., Hellhammer D.H., Giacchetti G., Vreugdenhil E., Zitman F.G., de Kloet E.R. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J. Clin. Endocrinol. Metab. 2006, 91:5083-5089. 10.1210/jc.2006-0915.
13. Giordano R., Bo M., Pellegrino M., Vezzari M., Baldi M., Picu A., Balbo M., Bonelli L., Migliaretti G., Ghigo E., Arvat E. Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade. J. Clin. Endocrinol. Metab. 2005, 10.1210/jc.2005-0105.
14. Heim C., Nemeroff C.B. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol. Psychiatry 2001, 49:1023-1039.
15. Heim C., Newport D.J., Mletzko T., Miller A.H., Nemeroff C.B. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 2008, 33:693-710. 10.1016/j.psyneuen.2008.03.008.
16. Heim C., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of early adverse life events in the etiology of depression and posttraumatic stress disorder. Focus on corticotropin-releasing factor. Ann. N.Y. Acad. Sci. 1997, 821:194-207.
17. Hovens J.G., Giltay E.J., Wiersma J.E., Spinhoven P., Penninx B.W., Zitman F.G. Impact of childhood life events and trauma on the course of depressive and anxiety disorders. Acta Psychiatr. Scand. 2012, 126:198-207. 10.1111/j.1600-0447.2011.01828.x.
18. Joëls M., Karst H., DeRijk R., de Kloet E.R. The coming out of the brain mineralocorticoid receptor. Trends Neurosci. 2008, 31:1-7. 10.1016/j.tins.2007.10.005.
19. Karandrea D., Kittas C., Kitraki E. Contribution of sex and cellular context in the regulation of brain corticosteroid receptors following restraint stress. Neuroendocrinology 2000, 71:343-353. 10.1159/000054555.
20. Karimi B., Hafidzi M., Panandam J., Fuzina N. Comparison of effect of sex hormone manipulation during neonatal period, on mRNA expression of Slc9a4, Nr3c2, Htr5b and Mas1 in hippocampus and frontal cortex of male and female rats. J. Biol. Regul. Homeost. Agents 2013, 27:869-874.
21. Karst H., Berger S., Erdmann G., Schutz G., Joels M. Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:14449-14454.
22. Karst H., Berger S., Turiault M., Tronche F., Schutz G., Joëls M. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:19204-19207. 10.1073/pnas.0507572102.
23. Kendler K.S., Gardner C.O., Neale M.C., Prescott C.A. Genetic risk factors for major depression in men and women: similar or different heritabilities and same or partly distinct genes?. Psychol. Med. 2001, 31:605-616. 10.1017/S0033291701003907.
24. Kendler K.S., Gatz M., Gardner C.O., Pedersen N.L. A Swedish national twin study of lifetime major depression. Am. J. Psychiatry 2006, 163:109-114. 10.1176/appi.ajp.163.1.109.
25. Kirschbaum C., Kudielka B.M., Gaab J., Schommer N.C., Hellhammer D.H. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom. Med. 1999, 61:154-162.
26. Kitraki E., Kremmyda O., Youlatos D., Alexis M.N., Kittas C. Gender-dependent alterations in corticosteroid receptor status and spatial performance following 21 days of restraint stress. Neuroscience 2004, 125:47-55. 10.1016/j.neuroscience.2003.12.024.
27. de Kloet E.R., Joëls M., Holsboer F., de Kloet E.R., Joels M. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6:463-475. 10.1038/nrn1683.
28. Klok M.D., Alt S.R., Irurzun Lafitte A.J., Turner J.D., Lakke E.A., Huitinga I., Muller C.P., Zitman F.G., de Kloet E.R., Derijk R.H. Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder. J. Psychiatr. Res. 2011, 45:871-878. 10.1016/j.jpsychires.2010.12.002.
29. Klok M.D., Giltay E.J., Van der Does A.J., Geleijnse J.M., Antypa N., Penninx B.W., de Geus E.J., Willemsen G., Boomsma D.I., van Leeuwen N., Zitman F.G., de Kloet E.R., DeRijk R.H. A common and functional mineralocorticoid receptor haplotype enhances optimism and protects against depression in females. Trans. Psychiatry 2011, 1:e62. 10.1038/tp.2011.59.
30. Klok M.D., Vreeburg S.A., Penninx B.W., Zitman F.G., de Kloet E.R., DeRijk R.H. Common functional mineralocorticoid receptor polymorphisms modulate the cortisol awakening response: interaction with SSRIs. Psychoneuroendocrinology 2011, 36:484-494. 10.1016/j.psyneuen.2010.07.024.
31. Kudielka B.M., Kirschbaum C. Sex differences in HPA axis responses to stress: a review. Biol. Psychol. 2005, 69:113-132.
32. Leeuwen N., Van Kumsta R., Entringer S., Kloet E.R., De Zitman F.G., Derijk R.H., Wu S., van Leeuwen N., de Kloet E.R., Wust S. Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone. Psychoneuroendocrinology 2010, 35:339-349. 10.1016/j.psyneuen.2009.07.006.
33. Llorente R., Miguel-Blanco C., Aisa B., Lachize S., Borcel E., Meijer O.C., Ramirez M.J., De Kloet E.R., Viveros M.P. Long term sex-dependent psychoneuroendocrine effects of maternal deprivation and juvenile unpredictable stress in rats. J. Neuroendocrinol. 2011, 23:329-344. 10.1111/j.1365-2826.2011.02109.x.
34. Lopez J.F., Chalmers D.T., Little K.Y., Watson S.J. Regulation of serotonin(1A), glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol. Psychiatry 1998, 43:547-573. 10.1016/S0006-3223(97)00484-8.
35. Medina A., Seasholtz A.F., Sharma V., Burke S., Bunney W., Myers R.M., Schatzberg A., Akil H., Watson S.J. Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder. J. Psychiatr. Res. 2013, 47:307-314. 10.1016/j.jpsychires.2012.11.002.
36. Monroe S.M. Modern approaches to conceptualizing and measuring human life stress. Annu. Rev. Clin. Psychol. 2008, 4:33-52. 10.1146/annurev.clinpsy.4.022007.141207.
37. Otte C., Hinkelmann K., Moritz S., Yassouridis A., Jahn H., Wiedemann K., Kellner M. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study. J. Psychiatr. Res. 2010, 44:339-346. 10.1016/j.jpsychires.2009.10.006.
38. Otte C., Yassouridis A., Jahn H., Maass P., Stober N., Wiedemann K., Kellner M. Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans. J. Gerontol. A, Biol. Sci. Med. Sci. 2003, 58:B900-B905.
39. Penninx B.W., Beekman A.T., Smit J.H., Zitman F.G., Nolen W.A., Spinhoven P., Cuijpers P., De Jong P.J., Van Marwijk H.W., Assendelft W.J., Van Der Meer K., Verhaak P., Wensing M., De Graaf R., Hoogendijk W.J., Ormel J., Van Dyck R. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int. J. Methods Psychiatr. Res. 2008, 17:121-140. 10.1002/mpr.256.
40. Piccinelli M., Wilkinson G. Gender differences in depression, critical review. Br. J. Psychiatry 2000, 177:486-492. 10.1192/bjp.177.6.486.
41. Quinkler M., Meyer B., Bumke-Vogt C., Grossmann C., Gruber U., Oelkers W., Diederich S., Bahr V. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor. Eur. J. Endocrinol. 2002, 146:789-799. 10.1530/eje.0.1460789.
42. Reul J.M., Gesing A., Droste S., Stec I.S., Weber A., Bachmann C., Bilang-Bleuel A., Holsboer F., Linthorst A.C. The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur. J. Pharmacol. 2000, 405:235-249.
43. Rozeboom A.M., Akil H., Seasholtz A.F. Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:4688-4693. 10.1073/pnas.0606067104.
44. Rush A.J., Gullion C.M., Basco M.R., Jarrett R.B., Trivedi M.H. The inventory of depressive symptomatology (IDS): psychometric properties. Psychol. Med. 1996, 26:477-486.
45. Schubart C.D., Sommer I.E., van Gastel W.A., Goetgebuer R.L., Kahn R.S., Boks M.P. Cannabis with high cannabidiol content is associated with fewer psychotic experiences. Schizophr. Res. 2011, 130:216-221. 10.1016/j.schres.2011.04.017.
46. Seckl J.R., Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology 1992, 55:621-626.
47. Ter Heegde F., DeRijk R.H., Vinkers C.H. The brain mineralocorticoid receptor and stress resilience. Psychoneuroendocrinology 2015, 52C:92-110. 10.1016/j.psyneuen.2014.10.022.
48. Ter Horst J.P., Carobrez A.P., van der Mark M.H., de Kloet E.R., Oitzl M.S. Sex differences in fear memory and extinction of mice with forebrain-specific disruption of the mineralocorticoid receptor. Eur. J. Neurosci. 2012, 36:3096-3102. 10.1111/j.1460-9568.2012.08237.x.
49. Ter Horst J.P., van der Mark M., Kentrop J., Arp M., van der Veen R., de Kloet E.R., Oitzl M.S. Deletion of the forebrain mineralocorticoid receptor impairs social discrimination and decision-making in male, but not in female mice. Front. Behav. Neurosci. 2014, 8:26. 10.3389/fnbeh.2014.00026.
50. Thombs B.D., Bernstein D.P., Lobbestael J., Arntz A. A validation study of the Dutch Childhood Trauma Questionnaire-short form: factor structure, reliability, and known-groups validity. Child Abus. Negl. 2009, 33:518-523. 10.1016/j.chiabu.2009.03.001.
51. Tingley D., Yamamoto T., Hirose K., Imai K., Keele L. Mediation: R package for causal mediation analysis. J. Stat. Software 2014, 59(5):1-38.
52. Turner B.B. Sex difference in glucocorticoid binding in rat pituitary is estrogen dependent. Life Sci. 1990, 46:1399-1406. 10.1016/0024-3205(90)90340-W.
53. Van Gastel W.A., Tempelaar W., Bun C., Schubart C.D., Kahn R.S., Plevier C., Boks M.P. Cannabis use as an indicator of risk for mental health problems in adolescents: a population-based study at secondary schools. Psychol. Med. 2012, 1-8. 10.1017/S0033291712002723.
54. Van Leeuwen N. Mineralocorticoid Receptor Gene Variants: Implications for Stress, Blood Pressure and Personality 2010, Leiden University, Leiden.
55. Van Leeuwen N., Bellingrath S., de Kloet E.R., Zitman F.G., DeRijk R.H., Kudielka B.M., Wüst S., Wust S. Human mineralocorticoid receptor (MR) gene haplotypes modulate MR expression and transactivation: implication for the stress response. Psychoneuroendocrinology 2011, 36:699-709. 10.1016/j.psyneuen.2010.10.003.
56. Vinkers C.H., Gastel W.A., Van Schubart C.D., Eijk K.R., Van Luykx J.J., Winkel R., Van Joëls M., Bruggeman R., Cahn W., Haan L., De Kahn R.S., Meijer C.J., Myin-germeys I., Os J., Van Wiersma D. The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val 158 Met polymorphism. Schizophr. Res. 2013, 150:303-311. 10.1016/j.schres.2013.07.020.
57. Watzka M., Beyenburg S., Blümcke I., Elger C.E., Bidlingmaier F., Stoffel-Wagner B. Expression of mineralocorticoid and glucocorticoid receptor mRNA in the human hippocampus. Neurosci. Lett. 2000, 290:121-124.